{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T19:06:14Z","timestamp":1774119974866,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T00:00:00Z","timestamp":1400544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Prim Care Resp Med"],"DOI":"10.1038\/npjpcrm.2014.3","type":"journal-article","created":{"date-parts":[[2014,5,19]],"date-time":"2014-05-19T14:12:35Z","timestamp":1400508755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Tiotropium in patients with moderate COPD naive to maintenance therapy: a randomised placebo-controlled trial"],"prefix":"10.1038","volume":"24","author":[{"given":"Thierry","family":"Troosters","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank C","family":"Sciurba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Decramer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikos M","family":"Siafakas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Solomon S","family":"Klioze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santosh C","family":"Sutradhar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Idelle M","family":"Weisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla","family":"Yunis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,20]]},"reference":[{"key":"BFnpjpcrm20143_CR1","unstructured":"Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global Strategy for the Diagnosis, Management and Prevention of COPD. http:\/\/www.goldcopd.org\/ 2013."},{"key":"BFnpjpcrm20143_CR2","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1016\/j.rmed.2006.03.034","volume":"100","author":"SG Adams","year":"2006","unstructured":"Adams SG, Anzueto A, Briggs DD Jr, Menjoge SS, Kesten S . Tiotropium in COPD patients not previously receiving maintenance respiratory medications. Respir Med 2006; 100: 1495\u20131503.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20143_CR3","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1159\/000068417","volume":"70","author":"O Kornmann","year":"2003","unstructured":"Kornmann O, Beeh KM, Beier J, Geis UP, Ksoll M, Buhl R . Newly diagnosed chronic obstructive pulmonary disease. Clinical features and distribution of the novel stages of the Global Initiative for Obstructive Lung Disease. Respiration 2003; 70: 67\u201375.","journal-title":"Respiration"},{"key":"BFnpjpcrm20143_CR4","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1056\/NEJMoa0805800","volume":"359","author":"DP Tashkin","year":"2008","unstructured":"Tashkin DP, Celli B, Senn S, Burkhart D, Kesten S, Menjoge S et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008; 359: 1543\u20131554.","journal-title":"N Engl J Med"},{"key":"BFnpjpcrm20143_CR5","doi-asserted-by":"publisher","first-page":"317","DOI":"10.7326\/0003-4819-143-5-200509060-00007","volume":"143","author":"DE Niewoehner","year":"2005","unstructured":"Niewoehner DE, Rice K, Cote C, Paulson D, Cooper JA Jr, Korducki L et al. Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial. Ann Intern Med 2005; 143: 317\u2013326.","journal-title":"Ann Intern Med"},{"key":"BFnpjpcrm20143_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1183\/09031936.02.00238702","volume":"19","author":"W Vincken","year":"2002","unstructured":"Vincken W, van Noord JA, Greefhorst AP, Bantje TA, Kesten S, Korducki L et al. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. Eur Respir J 2002; 19: 209\u2013216.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR7","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/S0140-6736(09)61298-8","volume":"374","author":"M Decramer","year":"2009","unstructured":"Decramer M, Celli B, Kesten S, Lystig T, Mehra S, Tashkin DP . Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial. Lancet 2009; 374: 1171\u20131178.","journal-title":"Lancet"},{"key":"BFnpjpcrm20143_CR8","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1164\/rccm.200712-1869OC","volume":"178","author":"BR Celli","year":"2008","unstructured":"Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178: 332\u2013338.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFnpjpcrm20143_CR9","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1465-9921-10-59","volume":"10","author":"CR Jenkins","year":"2009","unstructured":"Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT et al. Efficacy of salmeterol\/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study. Respir Res 2009; 10: 59.","journal-title":"Respir Res"},{"key":"BFnpjpcrm20143_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1183\/09031936.00127809","volume":"36","author":"T Troosters","year":"2010","unstructured":"Troosters T, Celli B, Lystig T, Kesten S, Mehra S, Tashkin DP et al. Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial. Eur Respir J 2010; 36: 65\u201373.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR11","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1378\/chest.128.3.1168","volume":"128","author":"F Maltais","year":"2005","unstructured":"Maltais F, Hamilton A, Marciniuk D, Hernandez P, Sciurba FC, Richter K et al. Improvements in symptom-limited exercise performance over 8 h with once-daily tiotropium in patients with COPD. Chest 2005; 128: 1168\u20131178.","journal-title":"Chest"},{"key":"BFnpjpcrm20143_CR12","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1378\/chest.127.3.809","volume":"127","author":"R Casaburi","year":"2005","unstructured":"Casaburi R, Kukafka D, Cooper CB, Witek TJ Jr, Kesten S . Improvement in exercise tolerance with the combination of tiotropium and pulmonary rehabilitation in patients with COPD. Chest 2005; 127: 809\u2013817.","journal-title":"Chest"},{"key":"BFnpjpcrm20143_CR13","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1183\/09031936.04.00116004","volume":"23","author":"DE O'Donnell","year":"2004","unstructured":"O'Donnell DE, Fluge T, Gerken F, Hamilton A, Webb K, Aguilaniu B et al. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. Eur Respir J 2004; 23: 832\u2013840.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR14","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1183\/09031936.00170111","volume":"40","author":"D Shrikrishna","year":"2012","unstructured":"Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012; 40: 1115\u20131122.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR15","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.rmed.2010.01.012","volume":"104","author":"T Troosters","year":"2010","unstructured":"Troosters T, Sciurba F, Battaglia S, Langer D, Valluri SR, Martino L et al. Physical inactivity in patients with COPD, a controlled multi-center pilot-study. Respir Med 2010; 104: 1005\u20131011.","journal-title":"Respir Med"},{"key":"BFnpjpcrm20143_CR16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1164\/rccm.200707-1011OC","volume":"177","author":"H Watz","year":"2008","unstructured":"Watz H, Waschki B, Boehme C, Claussen M, Meyer T, Magnussen H . Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: a cross-sectional study. Am J Respir Crit Care Med 2008; 177: 743\u2013751.","journal-title":"Am J Respir Crit Care Med"},{"key":"BFnpjpcrm20143_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2174\/1874306401105010001","volume":"5","author":"T Troosters","year":"2011","unstructured":"Troosters T, Weisman I, Dobbels F, Giardino N, Valluri SR . Assessing the impact of tiotropium on lung function and physical activity in GOLD stage II COPD patients who are naive to maintenance respiratory therapy: a study protocol. Open Respir Med J 2011; 5: 1\u20139.","journal-title":"Open Respir Med J"},{"key":"BFnpjpcrm20143_CR18","unstructured":"International Conference on Harmonisation. Good clinical practice guidelines. http:\/\/www.ich.org\/products\/guidelines\/. Accessed June 2013."},{"key":"BFnpjpcrm20143_CR19","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A et al. Standardisation of spirometry. Eur Respir J 2005; 26: 319\u2013338.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR20","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1183\/09031936.00134312","volume":"42","author":"RA Rabinovich","year":"2013","unstructured":"Rabinovich RA, Louvaris Z, Raste Y, Langer D, Van Remoortel H, Giavedoni S et al. Validity of physical activity monitors during daily life in patients with COPD. Eur Respir J 2013; 42: 1205\u20131215.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR21","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. Physical Activity and Health: A Report of the Surgeon General. Chapter 2: Historical Background, Terminology, Evolution of Recommendations and Measurement, 2011. http:\/\/www.cdc.gov\/nccdphp\/sgr\/chap2.htm."},{"key":"BFnpjpcrm20143_CR22","doi-asserted-by":"publisher","first-page":"198","DOI":"10.4104\/pcrj.2009.00032","volume":"18","author":"WC Bailey","year":"2009","unstructured":"Bailey WC, Sciurba FC, Hanania NA, Donohue JF, Ferguson GT, Zibrak JD et al. Development and validation of the Chronic Obstructive Pulmonary Disease Assessment Questionnaire (COPD-AQ). Prim Care Respir J 2009; 18: 198\u2013207.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20143_CR23","doi-asserted-by":"publisher","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","volume":"4","author":"MC Reilly","year":"1993","unstructured":"Reilly MC, Zbrozek AS, Dukes EM . The validity and reproducibility of a work productivity and activity impairment instrument. Pharmacoeconomics 1993; 4: 353\u2013365.","journal-title":"Pharmacoeconomics"},{"key":"BFnpjpcrm20143_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/1477-7525-1-18","volume":"1","author":"E Stahl","year":"2003","unstructured":"Stahl E, Jansson SA, Jonsson AC, Svensson K, Lundback B, Andersson F . Health-related quality of life, utility, and productivity outcomes instruments: ease of completion by subjects with COPD. Health Qual Life Outcomes 2003; 1: 18.","journal-title":"Health Qual Life Outcomes"},{"key":"BFnpjpcrm20143_CR25","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1183\/09031936.00024608","volume":"33","author":"H Watz","year":"2009","unstructured":"Watz H, Waschki B, Meyer T, Magnussen H . Physical activity in patients with COPD. Eur Respir J 2009; 33: 262\u2013272.","journal-title":"Eur Respir J"},{"key":"BFnpjpcrm20143_CR26","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-14-115","volume":"14","author":"T Troosters","year":"2013","unstructured":"Troosters T, Van Der Molen T, Polkey MI, Rabinovich RA, Vogiatzis I, Weisman I et al. Improving physical activity in COPD: towards a new paradigm. Respir Res 2013; 14: 1\u20138.","journal-title":"Respir Res"},{"key":"BFnpjpcrm20143_CR27","doi-asserted-by":"publisher","first-page":"e39198","DOI":"10.1371\/journal.pone.0039198","volume":"7","author":"H Van Remoortel","year":"2012","unstructured":"Van Remoortel H, Raste Y, Louvaris Z, Giavedoni S, Burtin C, Langer D et al. Validity of six activity monitors in chronic obstructive pulmonary disease: a comparison with indirect calorimetry. PLoS One 2012; 7: e39198.","journal-title":"PLoS One"},{"key":"BFnpjpcrm20143_CR28","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1479-5868-9-84","volume":"9","author":"H Van Remoortel","year":"2012","unstructured":"Van Remoortel H, Giavedoni S, Raste Y, Burtin C, Louvaris Z, Gimeno-Santos E et al. Validity of activity monitors in health and chronic disease: a systematic review. Int J Behav Nutr Phys Act 2012; 9: 84.","journal-title":"Int J Behav Nutr Phys Act"},{"key":"BFnpjpcrm20143_CR29","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1183\/09059180.00007809","volume":"19","author":"T Troosters","year":"2010","unstructured":"Troosters T, Gosselink R, Janssens W, Decramer M . Exercise training and pulmonary rehabilitation: new insights and remaining challenges. Eur Respir Rev 2010; 19: 24\u201329.","journal-title":"Eur Respir Rev"},{"key":"BFnpjpcrm20143_CR30","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S0140-6736(12)60735-1","volume":"380","author":"AE Bauman","year":"2012","unstructured":"Bauman AE, Reis RS, Sallis JF, Wells JC, Loos RJ, Martin BW . Correlates of physical activity: why are some people physically active and others not? Lancet 2012; 380: 258\u2013271.","journal-title":"Lancet"},{"key":"BFnpjpcrm20143_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.3132\/pcrj.2008.00037","volume":"17","author":"G Johansson","year":"2008","unstructured":"Johansson G, Lindberg A, Romberg K, Nordstrom L, Gerken F . Roquet A. Bronchodilator efficacy of tiotropium in patients with mild to moderate COPD. Prim Care Respir J 2008; 17: 169\u2013175.","journal-title":"Prim Care Respir J"},{"key":"BFnpjpcrm20143_CR32","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1186\/1471-2458-11-612","volume":"11","author":"MJ Fletcher","year":"2011","unstructured":"Fletcher MJ, Upton J, Taylor-Fishwick J, Buist SA, Jenkins C, Hutton J et al. COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population. BMC Public Health 2011; 11: 612.","journal-title":"BMC Public Health"}],"container-title":["npj Primary Care Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T04:03:57Z","timestamp":1672977837000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npjpcrm20143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,20]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,11,27]]}},"alternative-id":["BFnpjpcrm20143"],"URL":"https:\/\/doi.org\/10.1038\/npjpcrm.2014.3","relation":{},"ISSN":["2055-1010"],"issn-type":[{"value":"2055-1010","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,20]]},"assertion":[{"value":"8 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2013","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2014","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"TT has received fees as chair of the steering committee from Pfizer, consultancy fees from AstraZeneca and lecture fees from Boehringer Ingelheim, Chiesi and Novartis. FCS has received grants from GlaxoSmithKline, Pfizer, Boehringer Ingelheim, Forest Pharmaceuticals, Actelion, AstraZeneca, NIH and fees for advisory boards from GlaxoSmithKline, AstraZeneca and PneumRx. MD has received fees for advisory boards from Boehringer Ingelheim, GlaxoSmithKline, Nycomed and Altana, consultancy and lectures fees from Boehringer Ingelheim and GlaxoSmithKline, and grants from AstraZeneca. NMS has received consultancy fees from Novartis, Elpen, AstraZeneca and Pfizer, grants from GlaxoSmithKline and Takeda, and lecture fees from Novartis, Elpen, AstraZeneca and Pfizer. CY is an employee of Pfizer and a shareholder. SK, SCS and IMW were employees of Pfizer at the time of the study but are now currently employed by Novartis Pharmaceuticals, East Hanover, NJ, USA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14003"}}